Modulation of inflammatory responses by Wnt/β-catenin signaling in dendritic cells

A novel immunotherapy target for autoimmunity and cancer

Amol Suryawanshi, Raghu K. Tadagavadi, Daniel Swafford, Santhakumar Manicassamy

Research output: Contribution to journalReview article

27 Citations (Scopus)

Abstract

The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases.

Original languageEnglish (US)
Article number460
JournalFrontiers in immunology
Volume7
Issue numberOCT
DOIs
StatePublished - Oct 27 2016

Fingerprint

Catenins
Autoimmunity
Immunotherapy
Dendritic Cells
Wnt Signaling Pathway
Neoplasms
Physiological Phenomena
Biological Phenomena
Immune Tolerance
Critical Pathways
Cell Shape
Regulatory T-Lymphocytes
Immunity
Pathology
T-Lymphocytes

Keywords

  • Autoimmune diseases, antitumor immunity
  • Dendritic cells
  • Immune-tolerance
  • Immuno-oncology
  • Immunotherapy
  • Wnt
  • β-catenin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Modulation of inflammatory responses by Wnt/β-catenin signaling in dendritic cells : A novel immunotherapy target for autoimmunity and cancer. / Suryawanshi, Amol; Tadagavadi, Raghu K.; Swafford, Daniel; Manicassamy, Santhakumar.

In: Frontiers in immunology, Vol. 7, No. OCT, 460, 27.10.2016.

Research output: Contribution to journalReview article

@article{0dc52f8e2f6e48ab8886428e522b3a75,
title = "Modulation of inflammatory responses by Wnt/β-catenin signaling in dendritic cells: A novel immunotherapy target for autoimmunity and cancer",
abstract = "The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases.",
keywords = "Autoimmune diseases, antitumor immunity, Dendritic cells, Immune-tolerance, Immuno-oncology, Immunotherapy, Wnt, β-catenin",
author = "Amol Suryawanshi and Tadagavadi, {Raghu K.} and Daniel Swafford and Santhakumar Manicassamy",
year = "2016",
month = "10",
day = "27",
doi = "10.3389/fimmu.2016.00460",
language = "English (US)",
volume = "7",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "OCT",

}

TY - JOUR

T1 - Modulation of inflammatory responses by Wnt/β-catenin signaling in dendritic cells

T2 - A novel immunotherapy target for autoimmunity and cancer

AU - Suryawanshi, Amol

AU - Tadagavadi, Raghu K.

AU - Swafford, Daniel

AU - Manicassamy, Santhakumar

PY - 2016/10/27

Y1 - 2016/10/27

N2 - The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases.

AB - The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases.

KW - Autoimmune diseases, antitumor immunity

KW - Dendritic cells

KW - Immune-tolerance

KW - Immuno-oncology

KW - Immunotherapy

KW - Wnt

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84997208399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997208399&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2016.00460

DO - 10.3389/fimmu.2016.00460

M3 - Review article

VL - 7

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - OCT

M1 - 460

ER -